Steven Cohen’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Steven Cohen’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,074,867	Closed	-$7.9M	–	2578
2024 Q1	$7.9M	Sell	3,074,867 -900,000	-23%	-$2.2M	0.02%	804
2023 Q4	$8.11M	Sell	3,974,867 -1,950,000	-33%	-$3.56M	0.02%	756
2023 Q3	$10.2M	Sell	5,924,867 -1,648,813	-22%	-$2.93M	0.03%	650
2023 Q2	$14.8M	Sell	7,573,680 -106,187	-1%	-$249K	0.04%	474
2023 Q1	$21.4M	Hold	7,679,867	–	–	0.07%	343
2022 Q4	$26.5M	Buy	+7,679,867	New	+$21.9M	0.09%	271
2021 Q2	–	Sell	-174,000	Closed	-$1.64M	–	1213
2021 Q1	$1.64M	Buy	+174,000	New	+$2.4M	0.01%	754
2018 Q4	–	Sell	-10,000	Closed	-$142K	–	1267
2018 Q3	$142K	Buy	+10,000	New	+$142K	﹤0.01%	965

Other funds holding GRTS

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steven Cohen's GRTS Position: Q2 2024 in Review

Steven Cohen sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 3,074,867 shares — an estimated $7.9M sold.

Steven Cohen first reported a position in GRTS in Q3 2018 and held it in 8 quarters. The position peaked at $26.5M in Q4 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Steven Cohen reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Steven Cohen sold 3,074,867 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $7.9M.
Steven Cohen first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Steven Cohen's Gritstone bio, Inc. Common Stock position peaked at $26.5M in Q4 2022.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.